Altaire Pharmaceuticals Inc.
Close-out letter issued March 12, 2020 · Aquebogue, New York
- Inspection
- Mar 25 – Apr 19, 2019
- Pages
- 9
- FEI number
- 1000119582
In short: On March 12, 2020, FDA sent Altaire Pharmaceuticals Inc. in Aquebogue, New York (FEI 1000119582) a close-out letter, confirming that the issues in an earlier warning letter were addressed.
Inside this close-out letter
The full close-out letter
Every page of the close-out letter, exactly as written.
Get the full close-out letterThis inspection in context
Questions about this close-out letter
When was Altaire Pharmaceuticals Inc. inspected by FDA?
The inspection ran Mar 25 – Apr 19, 2019, and the Close-out letter is dated March 12, 2020.
How do I get the full Close-out letter for Altaire Pharmaceuticals Inc.?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.